Advocacy Update Aug. 26, 2025
IN THIS ISSUE / Aug. 26, 2025
FDA public workshop: Improving patch test access for contact dermatitis
Editor’s note: Next issue of Advocacy Update will be Sept. 9
Scope of Practice
AADA opposes pharmacist scope expansion
Over the past month, the AADA joined the American Medical Association and other specialty and state societies to oppose H.R. 3164/ S. 2426 (PDFs), the Ensuring Community Access to Pharmacist Services Act.
This legislation would inappropriately allow pharmacists to perform services that would normally only be authorized and covered if conducted by a physician, including testing and treating patients for certain illnesses. It would allow pharmacists to be eligible for Medicare reimbursement for testing and treatment of COVID-19, influenza, RSV, or streptococcal pharyngitis.
In addition to fighting scope creep, it was vitally important for the AADA to oppose this bill because adding these covered services would expand Medicare payment for pharmacists, which could mean less Medicare reimbursement for physicians.
Regulatory Affairs
FDA public workshop: Improving patch test access for contact dermatitis
The FDA announced a virtual public workshop on Oct. 23 regarding the approval of new patches for the diagnosis of allergic contact dermatitis. If you are interested in participating, please register.
AADA News
Still accepting applications for state advocacy grants
Does your state dermatology society need help with their advocacy? The AADA’s State Advocacy Grant Program provides financial assistance to state dermatology societies to advance their advocacy initiatives, including by helping to support state lobbying expenses. State dermatology societies seeking financial assistance from the AADA for their 2026 legislative efforts may apply until Sept. 30, 2025.
AADA News
Editor’s note: Next issue of Advocacy Update will be Sept. 9
Advocacy Update will take a scheduled break until Sept. 9. Check out the AADA’s @AADmember social media channels for any advocacy breaking news.
AADA News
Support SkinPAC to elect dermatology champions
As of Aug. 21, SkinPAC has raised $810,901 from 745 individuals. Contribute online at www.skinpac.org or by texting SkinPAC to 71777.
Help us keep up the momentum as we advocate for Medicare physician payment reform. SkinPAC helps strengthen our relationships on Capitol Hill and reinforces our grassroots and lobbying efforts.
Email skinpac@aad.org with any questions.
The political purpose of the American Academy of Dermatology Association Political Action Committee ("SkinPAC") is to solicit and receive contributions to be used to make political campaign expenditures to those candidates for elective office, and other federal political committees, who demonstrate understanding and interest in the view and goals of the American Academy of Dermatology Association.
Contributions to SkinPAC are not deductible for federal income tax purposes. Contributions to SkinPAC must be made from your funds and may not be reimbursed. SkinPAC cannot accept contributions from corporate accounts. Any recommended contribution amount is merely a suggestion. All AADA members have the right to contribute more or less or refuse to contribute without reprisal. Federal law prohibits us from accepting contributions from foreign nationals. Federal law requires us to use our best efforts to collect and report the name, physical address, occupation, and name of the employer whose contributions exceed $200 in a calendar year.
